Lv11
100 积分 2026-01-18 加入
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial
1小时前
待确认
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
3小时前
已完结
皖公网安备34019202002308
